163 related articles for article (PubMed ID: 37565303)
1. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement.
Wang X; Liu LL; Li Q; Xia QY; Li R; Ye SB; Zhang RS; Fang R; Chen H; Wu N; Rao Q
Histopathology; 2023 Nov; 83(5):798-809. PubMed ID: 37565303
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological and molecular features of metaplastic thymoma].
Wang X; Zhang RS; Li R; Ye SB; Li Q; Chen H; Xia QY; Wu N; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1237-1243. PubMed ID: 38058040
[No Abstract] [Full Text] [Related]
4. Significance of
Wang M; Xu H; Han Q; Wang L
Ann Med; 2023; 55(2):2237040. PubMed ID: 37489594
[TBL] [Abstract][Full Text] [Related]
5.
Zhao J; Zhao R; Xiang C; Shao J; Guo L; Han Y
Front Oncol; 2021; 11():692283. PubMed ID: 34354947
[TBL] [Abstract][Full Text] [Related]
6. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma.
Sekine S; Kiyono T; Ryo E; Ogawa R; Wakai S; Ichikawa H; Suzuki K; Arai S; Tsuta K; Ishida M; Sasajima Y; Goshima N; Yamazaki N; Mori T
J Clin Invest; 2019 May; 129(9):3827-3832. PubMed ID: 31145701
[TBL] [Abstract][Full Text] [Related]
7. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
8. Utility of YAP1 and NUT immunohistochemistry in the diagnosis of porocarcinoma.
Russell-Goldman E; Hornick JL; Hanna J
J Cutan Pathol; 2021 Mar; 48(3):403-410. PubMed ID: 33222286
[TBL] [Abstract][Full Text] [Related]
9. YAP1::MAML2 fusions in poromatosis: A report of two patients.
Mitsui Y; Ogawa K; Goto K; Fujii T; Nakamura-Nishimura Y; Mashiba K; Asada H
J Cutan Pathol; 2023 Aug; 50(8):695-701. PubMed ID: 36723803
[TBL] [Abstract][Full Text] [Related]
10. Giant Multilocular-Cystic Metaplastic Thymoma: A Case Report.
Han L; Gao B; Wang EH; Wang L
Pharmgenomics Pers Med; 2023; 16():463-466. PubMed ID: 37229516
[TBL] [Abstract][Full Text] [Related]
11. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of thymomas: implications for diagnosis and therapy.
Marx A; Belharazem D; Lee DH; Popovic ZV; Reißfelder C; Schalke B; Schölch S; Ströbel P; Weis CA; Yamada Y
Virchows Arch; 2021 Jan; 478(1):101-110. PubMed ID: 33674910
[TBL] [Abstract][Full Text] [Related]
13. A Rare Case of Metaplastic Thymoma Presenting With Myasthenia Gravis.
Vega Prado I; Shymansky J; Apte A; Mortman K; Kaminski HJ; Barak S
Int J Surg Pathol; 2024 Feb; 32(1):155-159. PubMed ID: 37093756
[TBL] [Abstract][Full Text] [Related]
14. Poroid adnexal skin tumors with YAP1 fusions exhibit similar histopathologic features: A series of six YAP1-rearranged adnexal skin tumors.
Prieto-Granada C; Morlote D; Pavlidakey P; Rodriguez-Waitkus P; Ramirez C; Florento E; Swensen J; Gatalica Z; Stevens TM
J Cutan Pathol; 2021 Sep; 48(9):1139-1149. PubMed ID: 33704800
[TBL] [Abstract][Full Text] [Related]
15. Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
Prieto-Granada CN; Inagaki H; Mueller J
Int J Surg Pathol; 2015 Jun; 23(4):277-83. PubMed ID: 25782731
[TBL] [Abstract][Full Text] [Related]
16. The Role of Gene Fusions in Thymic Epithelial Tumors.
Roden AC
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067300
[TBL] [Abstract][Full Text] [Related]
17. Expression of
Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Landscape Analysis Reveals Recurrent
Massoth LR; Hung YP; Dias-Santagata D; Onozato M; Shah N; Severson E; Duncan D; Gillespie BJ; Williams NF; Ross JS; Vergilio JA; Harkins SK; Glomski K; Nardi V; Zukerberg LR; Hasserjian RP; Louissaint A; Williams EA
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923872
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of NUT-positive poromas and porocarcinomas identifies novel break points of YAP1::NUTM1 fusions.
Snow JT; Georgantzoglou N; Green DC; Parra O; LeBlanc RE; Yan S; Sriharan A; Momtahen S; Winnick KN; Dimonitsas E; Stavrianos S; Lakiotaki E; Korkolopoulou P; Revelos K; Guo R; Linos K
J Cutan Pathol; 2022 Oct; 49(10):850-858. PubMed ID: 35665951
[TBL] [Abstract][Full Text] [Related]
20. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
Nobee A; Xu M; Seth A; Rong Y
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
